Ashfield, part of UDG Healthcare, an international healthcare services provider, has announced the appointment of Pierre Van Weperen as Commercial and Patient Solutions UK Managing Director.
Weperen has more than 17 years’ experience of leadership at Novo Nordisk, MSD and Wyeth, most recently leading Novo Nordisk’s UK Diabetes team and as the Executive Director for Primary Care (General Medicine) at MSD.
Nigel Mansford, Regional President for Ashfield Clinical and Commercial Europe and Canada, said: “Pierre is a charismatic and people focussed leader who will bring drive, energy and innovation to the role."
“He brings to us a rare blend of pharmaceutical sales and marketing expertise as well as services sector understanding. Pierre’s insight and knowledge of our market place will be invaluable as he guides future direction for the UK business.”
Weperen will be part of the Europe and Canada Management Team and will have responsibility for Ashfield’s Commercial and Patient Solutions operations in the UK from 3 September 2018.
Ashfield’s Commercial team provides contract sales services to pharma companies across Europe while the Patient Solutions department designs and delivers nurse-led patient support services.
Weperen said: “My ambition is to make a real difference at every organisation I join, and my role will allow me to improve outcomes for patients and companies alike while guiding the business strategically."
